Zurcher Kantonalbank Finance (Guernsey) Limited Share Price

Certificat

Z09GFZ

CH1329128206

Market Closed - Swiss Exchange 16:20:00 24/06/2024 BST
103.1 CHF +0.25% Intraday chart for Zurcher Kantonalbank Finance (Guernsey) Limited
Current month-0.27%
1 month-1.17%
Date Price Change
24/06/24 103.1 +0.25%
20/06/24 102.8 +0.03%
19/06/24 102.8 -0.27%
18/06/24 103.1 -0.26%

Delayed Quote Swiss Exchange

Last update June 24, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying PFIZER, INC.
Issuer ZKB
Z09GFZ
ISINCH1329128206
Date issued 22/04/2024
Strike 17.12 $
Maturity 22/04/2025 (301 Days)
Parity 1 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 105.3 CHF
Lowest since issue 100.6 CHF
Spread 5 CHF
Spread %0.48%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.99 USD
Average target price
31.92 USD
Spread / Average Target
+14.02%
Consensus
  1. Stock Market
  2. Certificates
  3. Z09GFZ Certificat